Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438095 · ClinicalTrials.gov registry record
Medication Adherence in Patients With Sarcoidosis
A clinical trial of Medication Adherence and Sarcoidosis, sponsored by Johns Hopkins University.
- Active
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT05438095: Active study of Medication Adherence and Sarcoidosis, sponsored by Johns Hopkins University.
NCT05438095 is a study of Medication Adherence and Sarcoidosis that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 150 participants, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438095, a study of Medication Adherence and Sarcoidosis, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the study is to look at the relationship between how individuals with Sarcoidosis take the sarcoidosis medicines and how it affects the disease, to evaluate any factors that may make individuals not want to take the medicines, and to develop and refine ways to help support individuals with Sarcoidosis especially when it comes to the medicines. The overall hypothesis is higher medication adherence will be associated with better clinical outcomes in sarcoidosis. The investigators will enroll 150 patients with biopsy proven pulmonary sarcoidosis for at least one year who are on any oral treatment regimen for at least six months into a 12-month longitudinal study.
Primary Outcome
The KSQ is a 29-item validated measure of sarcoidosis health status. Scores range from 0 to 100. Higher KSQ scores are better. Lower KSQ scores are worse.
Conditions Studied
Study Locations (2)
Maryland
- Johns Hopkins Bayview Asthma and Allergy Center - Baltimore
- Johns Hopkins Greenspring Station - Timonium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2026-08-31 |
What the registry record for NCT05438095 still lists
NCT05438095 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 0 interventions.
NCT05438095 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05438095 about?
NCT05438095 is a clinical study titled "Medication Adherence in Patients With Sarcoidosis". The goal of the study is to look at the relationship between how individuals with Sarcoidosis take the sarcoidosis medicines and how it affects the disease, to evaluate any factors that may make individuals not want to take the medicines, and to develop and refine ways to help support individuals wi...
What is the current status of trial NCT05438095?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2022-05-11. Estimated completion is 2026-08-31.
What conditions does trial NCT05438095 study?
This clinical trial studies the following conditions: Medication Adherence, Sarcoidosis.
Who is sponsoring clinical trial NCT05438095?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438095 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Adherence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05438095's enrollment target sits among peer trials
150 25th of 52 higher than 26 of 52 other Medication Adherence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Medication Adherence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Medication Adherence Program
RECRUITING · NA
-
An Integrated Intervention Using a Pill Ingestible Sensor System
RECRUITING · Phase 2
-
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
RECRUITING · NA
-
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI